Navigation Links
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Date:1/29/2010

GAITHERSBURG, Md., Jan. 29 /PRNewswire/ -- MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics.  Motavizumab is an investigational monoclonal antibody (MAb) being evaluated by the FDA for its potential to prevent serious disease caused by respiratory syncytial virus (RSV) among infants at high risk.

The phase 3, pivotal trial assessed the safety and RSV hospitalization in 6,635 preterm infants aged six months or younger at enrollment or children aged 24 months or younger with chronic lung disease of prematurity who received either 15 mg/kg palivizumab or motavizumab monthly.  Secondary endpoints included outpatient medically attended lower respiratory tract infections (MALRIs), RSV-specific MALRIs, otitis media, antibiotic use, development of anti-motavizumab antibodies and motavizumab serum concentrations.

In this first head-to-head trial, motavizumab demonstrated non-inferiority, but not superiority, to Synagis® (palivizumab), meeting the primary endpoint with a 26 percent relative reduction in RSV hospitalizations versus Synagis (p<0.01 for non-inferiority) due to RSV. Motavizumab also demonstrated superiority compared to Synagis, with a 50 percent relative reduction in RSV lower respiratory tract infections requiring outpatient management (p=0.005), which was one of the secondary endpoints of the trial. Other secondary endpoints were not statistically significant. Adverse events were similar in both groups, although, motavizumab had two percentage points more adverse events reported for the skin compared to Synagis; the majority were non-specific rashes that did not recur or affect dosing.

In '/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Conn., March 30, 2011 Attendees of the 60th ... New Orleans, La., can see first hand the benefits ... Available for sale in the U.S., Synapse 3D is ... directly into Synapse® Cardiovascular, Fujifilm,s CVIS / C-PACS. During ...
... PORT WASHINGTON, N.Y., March 30, 2011 Premier Heart, LLC ... 11, the 60th Annual Scientific Sessions and Expo of the ... in New Orleans. The MCG offers completely non-invasive cardiac testing ... diagnosis" according to its latest US FDA 510K Clearance.  MCG ...
Cached Medicine Technology:Fujifilm Highlights Synapse® 3D at ACC 2Fujifilm Highlights Synapse® 3D at ACC 3Premier Heart to Exhibit its Multifunction CardioGram (MCG™) at American College of Cardiology in New Orleans April 2-5 2
(Date:7/11/2014)... Newport Beach, CA (PRWEB) July 11, 2014 ... product pure Artichoke Leaf Extract dietary supplements to aid ... flow, an action necessary to facilitate metabolism of fat. ... facilities, Superior Labs Artichoke Leaf Extract is available in ... of pure artichoke extract. , Health Benefits of ...
(Date:7/11/2014)... Plasma resource reserves and control are crucial ... closure of 16 plasma collection stations in Guizhou in ... market, the total plasma volume in China blood products ... lot release volume declined by 7% from a year ... of new plasma stations and production break of some ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 People with ... are just some of the increasing numbers of people ... lead more independent and productive lives. , But ... Or is an assistance dog an impediment to employment? ... Week , August 3 - 9, 2014, West Virginia ...
(Date:7/11/2014)... 2014 Yisrayl Hawkins, Pastor and Overseer of ... pleading to let the children from other nations, who are ... come. Yisrayl says President Barack Obama is fighting to let ... States, and he wants to help him. , “It ... Honduras and El Salvador being treated as if they are ...
(Date:7/11/2014)... 2014 New Albany dental expert Dr. ... idea of paying $20,000 for new teeth. , “The cost may ... for many patients,” Dr. Receveur said. , For those who have ... have a lifetime of embarrassment over their smile, dental implant ... a better, more enjoyable life. , Still, Dr. Receveur knows that ...
Breaking Medicine News(10 mins):Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4Health News:Will Your Next Employee or Co-Worker Be a Dog? 2Health News:Will Your Next Employee or Co-Worker Be a Dog? 3Health News:Will Your Next Employee or Co-Worker Be a Dog? 4Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 2Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 3Health News:Louisville Dental Expert Offers 5 Tips for Deciding Whether Cost or Value of Dental Implants are More Important 4
... , , WASHINGTON , ... Center hosts a symposium exploring the future of cancer research on ... (GUMC).  Sponsored by the Ruesch Center for the Cure of Gastrointestinal ... Personalized Medicine & the Cure for Cancer, " will offer a ...
... Mo. , Feb. 12 The Reliv Kalogris ... $450,000 worth of children,s nutritional supplements to Haitian ... 3,000 cases of Reliv Now for Kids, a supplement containing ... to strengthen children,s health. Reliv produces nutritional supplements that are ...
... February 12, 2010 Giving chocolates to your Valentine on ... on a preliminary study from researchers at St. Michael,s Hospital. ... of Neurology in April, also found that eating chocolate may ... "Though more research is needed to determine whether chocolate is ...
... , Medication Delivered Under the Tongue May Be Alternative ... An oral allergy treatment administered in drops under the tongue ... are allergic to ragweed pollen, according to a study published today ... specialist at Allegheny General Hospital.   , Widely used in ...
... , 75% Say the U.S. ... Feb. 12 More than half (57%) of registered American voters ... Afghanistan , and half (52%) also approve of the way ... of the way the president is dealing with the country,s economic ...
... , THE WOODLANDS, Texas , Feb. 12 ... staff interested in learning the most important aspects to be aware ... for your particular practice are invited to attend a free webinar ... on Thursday, Feb. 18, 2010 . To register, ...
Cached Medicine News:Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 2Health News:GUMC's Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine 3Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 2Health News:Reliv Foundation Donates $450,000 In Nutritional Supplements to Haitian Relief Efforts 3Health News:Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment 2Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 2Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 3Health News:Majority of Americans Approve of President Obama's Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television 4Health News:What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar 2Health News:What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: